Fri, October 1, 2021
Thu, September 30, 2021
Wed, September 29, 2021
Tue, September 28, 2021
Mon, September 27, 2021
Sun, September 26, 2021
Fri, September 24, 2021
Thu, September 23, 2021
Wed, September 22, 2021
Tue, September 21, 2021
Mon, September 20, 2021
Fri, September 17, 2021
Thu, September 16, 2021

Zegbeh Jallah Maintained (SYRS) at Strong Buy with Increased Target to $230 on, Sep 23rd, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-230-on-sep-23rd-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Zegbeh Jallah of Roth Capital, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Strong Buy with Increased Target from $200 to $230 on, Sep 23rd, 2021.

Zegbeh, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30